Free Trial

Delek US (DK) Financials

Delek US logo
$12.12 -0.42 (-3.31%)
Closing price 04/15/2025 03:59 PM Eastern
Extended Trading
$12.15 +0.03 (+0.21%)
As of 04/15/2025 06:33 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for Delek US

Annual Income Statements for Delek US

This table shows Delek US's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Net Income / (Loss) Attributable to Common Shareholders
19 -154 289 340 311 -611 -128 257 20 -560
Consolidated Net Income / (Loss)
44 -133 323 375 336 -574 -95 291 47 -521
Net Income / (Loss) Continuing Operations
37 -220 329 384 331 -574 -95 265 20 -598
Total Pre-Tax Income
21 -391 299 486 403 -767 -137 322 17 -706
Total Operating Income
69 -49 180 612 492 -732 -35 458 245 -492
Total Gross Profit
545 32 432 973 890 -261 251 748 549 -43
Total Revenue
4,782 4,198 7,267 10,233 9,298 7,302 10,648 19,801 16,467 11,852
Operating Revenue
4,782 4,198 7,267 10,233 9,298 7,302 10,648 19,801 16,467 11,852
Total Cost of Revenue
4,237 4,166 6,835 9,260 8,408 7,563 10,398 19,053 15,919 11,895
Operating Cost of Revenue
4,237 4,166 6,835 9,260 8,408 7,563 10,398 19,053 15,919 11,895
Total Operating Expenses
476 81 251 361 398 471 285 290 304 448
Selling, General & Admin Expense
371 106 176 248 275 235 200 314 272 253
Depreciation Expense
106 10 21 38 24 26 25 11 17 25
Other Operating Expenses / (Income)
-0.50 7.10 54 75 100 85 83 -3.50 -2.50 -52
Impairment Charge
- 0.00 0.00 0.00 0.00 126 0.00 0.00 38 244
Other Special Charges / (Income)
0.00 -42 - - - 0.00 -23 -31 -20 -21
Total Other Income / (Expense), net
-47 -342 119 -126 -90 -35 -103 -136 -228 -215
Interest & Investment Income
3.10 -287 17 16 46 30 18 -138 -232 -221
Other Income / (Expense), net
1.60 -0.40 196 -6.90 -4.10 60 16 2.40 3.70 6.30
Income Tax Expense
-16 -172 -29 102 72 -194 -42 56 -3.00 -108
Net Income / (Loss) Discontinued Operations
6.60 86 -5.90 -8.70 5.20 - - 25 27 77
Net Income / (Loss) Attributable to Noncontrolling Interest
24 20 34 35 26 38 33 33 27 40
Basic Earnings per Share
$0.32 ($2.49) $4.04 $4.11 $4.10 ($8.31) ($1.73) $3.63 $0.30 ($8.77)
Weighted Average Basic Shares Outstanding
60.82M 61.92M 71.57M 82.80M 75.85M 73.60M 73.98M 70.79M 65.41M 63.88M
Diluted Earnings per Share
$0.32 ($2.49) $4.00 $3.95 $4.06 ($8.31) ($1.73) $3.59 $0.30 ($8.77)
Weighted Average Diluted Shares Outstanding
61.32M 61.92M 72.30M 86.77M 76.57M 73.60M 73.98M 71.52M 65.41M 63.88M
Weighted Average Basic & Diluted Shares Outstanding
- - 83.92M 78.01M 73.41M 73.78M 74.20M 66.94M 64.02M 62.51M
Cash Dividends to Common per Share
$0.60 $0.60 $0.60 $0.96 $1.14 $0.93 $0.00 $0.61 $0.93 $1.01

Quarterly Income Statements for Delek US

This table shows Delek US's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Net Income / (Loss) Attributable to Common Shareholders
7.40 -119 64 -8.30 129 -165 -33 -37 -77 -414
Consolidated Net Income / (Loss)
17 -110 72 -1.50 136 -160 -25 -26 -68 -402
Net Income / (Loss) Continuing Operations
17 -135 72 -1.50 126 -177 -25 -26 -135 -412
Total Pre-Tax Income
21 -186 88 -5.30 155 -221 -32 -34 -175 -465
Total Operating Income
53 -136 143 50 212 -160 33 14 -122 -416
Total Gross Profit
141 -139 237 158 278 -124 130 57 -20 -210
Total Revenue
5,325 4,034 3,924 4,196 4,629 3,719 3,228 3,422 3,042 2,161
Operating Revenue
5,325 4,034 3,924 4,196 4,629 3,719 3,228 3,422 3,042 2,161
Total Cost of Revenue
5,184 4,174 3,687 4,038 4,351 3,843 3,098 3,365 3,063 2,370
Operating Cost of Revenue
5,184 4,174 3,687 4,038 4,351 3,843 3,098 3,365 3,063 2,370
Total Operating Expenses
88 -3.90 94 108 66 36 97 43 102 206
Selling, General & Admin Expense
59 82 72 76 68 57 64 63 70 55
Depreciation Expense
6.40 -6.00 6.60 6.80 4.00 -0.70 8.80 11 5.60 -1.00
Other Operating Expenses / (Income)
22 -49 16 25 -5.80 -38 24 -54 17 -39
Total Other Income / (Expense), net
-32 -50 -55 -55 -57 -61 -65 -47 -53 -49
Interest & Investment Income
18 -183 15 26 -55 -217 22 30 -54 -219
Other Income / (Expense), net
0.70 -0.60 7.10 -0.50 -2.00 -0.90 0.70 0.00 0.50 5.10
Income Tax Expense
4.00 -51 16 -3.80 29 -44 -7.20 -7.70 -40 -53
Net Income / (Loss) Attributable to Noncontrolling Interest
9.40 9.00 7.90 6.80 7.40 4.80 7.40 11 9.30 12
Basic Earnings per Share
$0.11 ($1.68) $0.96 ($0.13) $1.98 ($2.51) ($0.51) ($0.58) ($1.20) ($6.48)
Weighted Average Basic Shares Outstanding
70.47M 70.79M 66.95M 65.77M 64.89M 65.41M 64.02M 64.21M 64.06M 63.88M
Diluted Earnings per Share
$0.10 ($1.65) $0.95 ($0.13) $1.97 ($2.49) ($0.51) ($0.58) ($1.20) ($6.48)
Weighted Average Diluted Shares Outstanding
71.11M 71.52M 67.37M 65.77M 65.46M 65.41M 64.02M 64.21M 64.06M 63.88M
Weighted Average Basic & Diluted Shares Outstanding
69.69M 66.94M 65.73M 64.82M 63.93M 64.02M 64.13M 64.54M 63.20M 62.51M

Annual Cash Flow Statements for Delek US

This table details how cash moves in and out of Delek US's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Net Change in Cash & Equivalents
-142 387 253 137 -124 -168 69 -15 -19 -87
Net Cash From Operating Activities
180 248 320 560 575 -283 371 425 1,014 -67
Net Cash From Continuing Operating Activities
144 235 322 590 575 -283 371 394 979 -84
Net Income / (Loss) Continuing Operations
37 -220 329 375 336 -574 -95 265 20 -598
Consolidated Net Income / (Loss)
44 -133 323 375 336 -574 -95 291 47 -521
Net Income / (Loss) Discontinued Operations
6.60 86 -5.90 - - - - 25 27 77
Depreciation Expense
106 116 153 199 194 268 265 275 340 375
Non-Cash Adjustments To Reconcile Net Income
-4.50 366 -24 -85 101 2.10 284 167 -87 294
Changes in Operating Assets and Liabilities, net
1.30 -32 -136 101 -56 21 -82 -314 707 -154
Net Cash From Discontinued Operating Activities
36 13 -2.10 -30 - - - 32 35 17
Net Cash From Investing Activities
-460 201 38 -125 -691 -191 -178 -932 -408 -242
Net Cash From Continuing Investing Activities
-435 -88 25 -145 -691 -191 -178 -901 -382 -603
Purchase of Property, Plant & Equipment
-188 -46 -172 -322 -413 -269 -222 -280 -393 -428
Acquisitions
-249 -62 185 -1.90 -287 -34 -2.70 -631 -4.30 -205
Purchase of Investments
- - - - - - 0.00 0.00 -12 -0.40
Sale of Property, Plant & Equipment
1.20 0.20 0.10 67 16 0.20 12 0.20 1.90 10
Sale and/or Maturity of Investments
- 20 12 1.20 0.80 72 10 9.90 15 5.00
Other Investing Activities, net
- - 0.00 0.00 -8.00 0.00 24 0.00 10 14
Net Cash From Discontinued Investing Activities
-25 289 12 20 - - - -30 -26 362
Net Cash From Financing Activities
139 -62 -105 -298 -7.90 306 -124 491 -625 222
Net Cash From Continuing Financing Activities
91 -44 -105 -298 -7.90 306 -124 491 -625 222
Repayment of Debt
-417 -385 -1,350 -2,520 -1,590 -1,922 -2,755 -4,831 -5,226 -8,928
Repurchase of Preferred Equity
- - - - - - - 0.00 0.00 -71
Repurchase of Common Equity
-42 -6.00 -25 -365 -178 -1.90 0.00 -194 -85 -42
Payment of Dividends
-58 -62 -87 -80 -87 -98 0.00 -79 -60 -64
Issuance of Debt
612 409 1,408 2,815 1,869 2,068 1,739 4,635 3,546 7,981
Issuance of Common Equity
- - - - 0.00 0.00 0.00 3.10 0.00 298
Other Financing Activities, net
-2.90 -1.10 -51 -148 -23 260 892 956 1,202 1,047
Cash Interest Paid
49 52 82 120 126 124 125 189 329 305
Cash Income Taxes Paid
5.10 1.70 71 104 94 3.60 4.20 28 11 3.80

Quarterly Cash Flow Statements for Delek US

This table details how cash moves in and out of Delek US's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Net Change in Cash & Equivalents
-91 -313 24 -43 80 -80 -69 -96 380 -302
Net Cash From Operating Activities
130 -291 395 95 433 91 167 -48 -22 -164
Net Cash From Continuing Operating Activities
130 -322 395 95 402 87 167 -48 -39 -163
Net Income / (Loss) Continuing Operations
17 -135 72 -1.50 112 -163 -25 -26 -146 -401
Consolidated Net Income / (Loss)
17 -110 72 -1.50 136 -160 -25 -26 -68 -402
Net Income / (Loss) Discontinued Operations
- - - - - 3.20 - - - -1.00
Depreciation Expense
73 66 83 89 82 84 95 92 91 96
Non-Cash Adjustments To Reconcile Net Income
-120 45 -50 -104 74 -8.00 102 -2.80 -76 270
Changes in Operating Assets and Liabilities, net
161 -298 289 111 133 174 -5.60 -112 91 -128
Net Cash From Discontinued Operating Activities
- - - - - 3.50 - - - -0.90
Net Cash From Investing Activities
-99 -112 -222 -58 -59 -69 -42 -63 78 -216
Net Cash From Continuing Investing Activities
-99 -82 -222 -58 -41 -61 -42 -63 -283 -216
Purchase of Property, Plant & Equipment
-95 -87 -211 -66 -43 -72 -47 -86 -104 -191
Acquisitions
-4.40 -1.30 -0.60 -0.70 -1.30 -1.70 -0.70 -0.60 -178 -25
Purchase of Investments
- - -7.50 -1.50 -2.00 -0.90 0.00 -0.40 -0.30 0.30
Sale of Property, Plant & Equipment
0.10 -1.00 - - 0.60 0.60 - - 1.10 -0.40
Sale and/or Maturity of Investments
- 8.20 2.10 5.20 3.20 4.40 2.80 0.60 0.70 0.90
Other Investing Activities, net
- - -4.80 4.80 1.50 8.80 3.60 14 -2.50 -1.30
Net Cash From Financing Activities
-122 90 -149 -81 -294 -101 -194 15 323 77
Net Cash From Continuing Financing Activities
-122 90 -149 -81 -294 -101 -194 15 323 77
Repayment of Debt
-380 -3,065 -1,366 -1,033 -1,564 -1,265 -2,544 -1,832 -2,047 -2,505
Repurchase of Common Equity
-40 -90 -0.40 -40 -25 -20 0.00 - -20 -22
Payment of Dividends
-28 -51 -24 -25 3.90 -15 -26 -6.20 -16 -16
Issuance of Debt
101 3,064 849 698 1,068 930 2,143 1,723 2,734 1,382
Issuance of Common Equity
- - 0.00 - - - 132 -0.10 - 166
Other Financing Activities, net
226 228 392 318 222 269 100 131 -328 1,143
Cash Interest Paid
38 75 106 54 72 97 75 70 88 71
Cash Income Taxes Paid
17 1.10 0.10 6.50 1.70 2.50 0.00 3.20 0.30 0.30

Annual Balance Sheets for Delek US

This table presents Delek US's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024
Total Assets
2,980 5,935 5,761 7,016 6,134 6,813 8,193 7,172 6,666
Total Current Assets
1,397 2,612 2,420 2,963 2,300 3,020 3,717 2,666 2,332
Cash & Equivalents
689 932 1,079 955 788 857 841 822 736
Accounts Receivable
266 582 514 793 528 777 1,234 784 618
Inventories, net
392 808 678 947 728 1,261 1,519 941 893
Other Current Assets
49 130 149 269 256 126 123 78 86
Other Current Nonoperating Assets
0.00 160 - - - - - 42 0.00
Plant, Property, & Equipment, net
1,103 2,141 2,195 2,428 2,367 2,307 2,776 2,696 2,940
Plant, Property & Equipment, gross
1,588 2,773 3,000 3,363 3,520 3,645 4,349 4,460 4,948
Accumulated Depreciation
484 632 805 935 1,152 1,338 1,573 1,764 2,008
Total Noncurrent Assets
480 1,183 1,145 1,625 1,467 1,486 1,700 1,810 1,394
Long-Term Investments
360 138 130 407 364 344 360 361 393
Goodwill
12 817 858 856 730 730 744 688 475
Intangible Assets
27 101 104 110 108 103 316 288 322
Other Noncurrent Operating Assets
81 127 53 251 266 309 280 246 204
Other Noncurrent Nonoperating Assets
- - - - - - - 228 0.00
Total Liabilities & Shareholders' Equity
2,980 5,935 5,761 7,016 6,134 6,813 8,193 7,172 6,666
Total Liabilities
1,797 3,971 3,953 5,181 5,009 5,799 7,123 6,212 6,091
Total Current Liabilities
935 2,672 1,664 2,356 1,903 3,127 3,086 2,685 2,516
Short-Term Debt
84 590 32 36 33 92 75 45 9.50
Accounts Payable
496 975 1,011 1,600 1,144 1,695 1,746 1,814 1,814
Other Current Liabilities
354 1,001 620 720 726 1,339 1,266 815 693
Other Current Nonoperating Liabilities
0.00 106 - - - - - 12 0.00
Total Noncurrent Liabilities
862 1,299 2,289 2,825 3,106 2,672 4,037 3,527 3,575
Long-Term Debt
749 875 1,751 2,031 2,315 2,126 2,979 2,555 2,756
Asset Retirement Reserve & Litigation Obligation
11 141 215 207 145 148 153 147 58
Noncurrent Deferred & Payable Income Tax Liabilities
76 200 210 268 256 215 267 264 215
Other Noncurrent Operating Liabilities
26 83 113 320 390 184 638 526 546
Other Noncurrent Nonoperating Liabilities
- - - - - - - 34 0.00
Total Equity & Noncontrolling Interests
1,183 1,964 1,808 1,835 1,125 1,014 1,070 960 575
Total Preferred & Common Equity
992 1,651 1,633 1,666 1,007 894 944 846 313
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
992 1,651 1,633 1,666 1,007 894 944 846 313
Common Stock
651 901 1,136 1,153 1,186 1,207 1,135 1,114 1,217
Retained Earnings
522 768 982 1,206 522 385 508 430 -206
Treasury Stock
-161 -25 -514 -692 -694 -694 -694 -694 -694
Accumulated Other Comprehensive Income / (Loss)
-21 6.90 29 0.10 -7.20 -3.80 -5.20 -4.80 -4.10
Noncontrolling Interest
191 314 176 169 118 120 126 114 262

Quarterly Balance Sheets for Delek US

This table presents Delek US's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024
Total Assets
8,397 7,787 7,770 7,869 7,180 6,944 7,030
Total Current Assets
4,030 3,187 3,196 3,333 2,708 2,501 2,565
Cash & Equivalents
1,154 865 822 902 753 658 1,038
Accounts Receivable
1,036 848 1,004 1,167 832 771 562
Inventories, net
1,634 1,315 1,276 1,179 1,038 1,010 915
Other Current Assets
206 159 95 86 85 61 51
Other Current Nonoperating Assets
- - - - - - 0.00
Plant, Property, & Equipment, net
2,678 2,882 2,869 2,835 2,804 2,786 2,829
Plant, Property & Equipment, gross
4,192 4,529 4,577 4,603 4,736 4,799 4,791
Accumulated Depreciation
1,514 1,647 1,708 1,768 1,932 2,014 1,962
Total Noncurrent Assets
1,689 1,718 1,704 1,701 1,668 1,657 1,637
Long-Term Investments
361 354 364 371 370 387 409
Goodwill
744 744 744 744 729 729 688
Intangible Assets
321 310 305 300 291 284 329
Other Noncurrent Operating Assets
264 309 291 285 277 256 212
Other Noncurrent Nonoperating Assets
- - - - - - 0.00
Total Liabilities & Shareholders' Equity
8,397 7,787 7,770 7,869 7,180 6,944 7,030
Total Liabilities
7,114 6,662 6,707 6,712 6,145 5,961 6,085
Total Current Liabilities
3,829 2,870 2,915 3,003 2,607 2,565 2,467
Short-Term Debt
63 50 50 30 15 9.50 9.50
Accounts Payable
2,150 1,794 1,990 2,007 1,732 1,861 1,714
Other Current Liabilities
1,616 1,026 875 966 860 694 744
Other Current Nonoperating Liabilities
- - - - - - 0.00
Total Noncurrent Liabilities
3,285 3,793 3,792 3,709 3,539 3,396 3,618
Long-Term Debt
2,671 2,726 2,761 2,609 2,482 2,452 2,780
Asset Retirement Reserve & Litigation Obligation
153 154 154 155 154 59 58
Noncurrent Deferred & Payable Income Tax Liabilities
310 284 281 304 270 262 244
Other Noncurrent Operating Liabilities
151 630 596 642 633 623 536
Other Noncurrent Nonoperating Liabilities
- - - - - - 0.00
Redeemable Noncontrolling Interest
- - - - - - 70
Total Equity & Noncontrolling Interests
1,283 1,124 1,063 1,157 1,035 983 875
Total Preferred & Common Equity
1,160 1,000 941 1,038 855 806 703
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
1,160 1,000 941 1,038 855 806 703
Common Stock
1,127 1,142 1,123 1,117 1,173 1,177 1,174
Retained Earnings
732 557 518 620 382 328 229
Treasury Stock
-694 -694 -694 -694 -694 -694 -694
Accumulated Other Comprehensive Income / (Loss)
-4.00 -5.20 -5.30 -5.30 -4.80 -4.80 -4.80
Noncontrolling Interest
123 124 122 119 180 177 172

Annual Metrics and Ratios for Delek US

This table displays calculated financial ratios and metrics derived from Delek US's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Growth Metrics
- - - - - - - - - -
Revenue Growth
0.00% -12.21% 73.11% 40.81% -9.14% -21.47% 45.83% 85.96% -16.84% -28.03%
EBITDA Growth
0.00% -60.92% 651.49% 51.83% -15.15% -159.25% 160.76% 199.10% -20.00% -118.83%
EBIT Growth
0.00% -170.55% 859.07% 60.69% -19.31% -237.65% 97.19% 2,533.33% -45.99% -295.33%
NOPAT Growth
0.00% -128.78% 674.59% 144.31% -16.30% -226.68% 95.26% 1,653.38% -23.43% -219.08%
Net Income Growth
0.00% -405.26% 341.83% 16.21% -10.32% -270.67% 83.39% 404.83% -83.92% -1,215.42%
EPS Growth
0.00% -878.13% 260.64% -1.25% 2.78% -304.68% 79.18% 307.51% -91.64% -3,023.33%
Operating Cash Flow Growth
0.00% 37.78% 28.91% 75.26% 2.66% -149.18% 231.28% 14.51% 138.33% -106.59%
Free Cash Flow Firm Growth
0.00% 0.00% -14.10% 135.69% -39.47% -219.69% 190.35% -292.53% 306.03% -138.07%
Invested Capital Growth
0.00% 0.00% 138.65% 3.30% 6.63% -8.56% -12.53% 43.85% -26.32% 2.73%
Revenue Q/Q Growth
0.00% 0.00% 0.00% -0.09% -2.01% -5.21% 13.01% 4.91% -4.42% -14.49%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% 10.16% -17.05% -397.42% 422.44% -18.25% -7.94% -163.51%
EBIT Q/Q Growth
0.00% 0.00% 0.00% 12.89% -21.65% -119.39% 94.78% -25.92% -18.72% -142.24%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% -23.36% -18.29% -100.25% 90.82% -22.80% -6.94% -144.77%
Net Income Q/Q Growth
0.00% 0.00% 0.00% -20.67% -21.01% -131.93% 74.83% -26.47% -51.91% -86.77%
EPS Q/Q Growth
0.00% 0.00% 0.00% -29.08% -20.39% -117.54% 68.94% -29.19% -73.68% -83.47%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 60.73% 24.93% -28.77% -3.63% 13.54% -51.52% 60.38% -135.63%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% -52.32% 37.53% -38.52% -38,575.05% 264.09% -532.88%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% -5.44% 1.73% -14.41% 0.82% 16.79% -14.63% -3.35%
Profitability Metrics
- - - - - - - - - -
Gross Margin
11.40% 0.76% 5.94% 9.51% 9.57% -3.57% 2.35% 3.78% 3.33% -0.36%
EBITDA Margin
3.77% 1.68% 7.29% 7.86% 7.34% -5.54% 2.31% 3.71% 3.57% -0.93%
Operating Margin
1.44% -1.17% 2.48% 5.98% 5.29% -10.03% -0.33% 2.31% 1.49% -4.15%
EBIT Margin
1.47% -1.18% 5.18% 5.91% 5.25% -9.20% -0.18% 2.32% 1.51% -4.09%
Profit (Net Income) Margin
0.91% -3.18% 4.44% 3.66% 3.62% -7.86% -0.90% 1.47% 0.28% -4.40%
Tax Burden Percent
205.16% 34.10% 107.78% 77.22% 83.49% 74.77% 69.41% 90.27% 281.33% 73.78%
Interest Burden Percent
30.30% 788.71% 79.50% 80.25% 82.49% 114.20% 726.46% 69.97% 6.68% 145.51%
Effective Tax Rate
-74.18% 0.00% -9.76% 20.99% 17.80% 0.00% 0.00% 17.53% -18.07% 0.00%
Return on Invested Capital (ROIC)
0.00% -7.13% 12.10% 20.63% 16.44% -21.09% -1.12% 15.23% 11.39% -15.76%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 84.37% 211.15% -3.10% 5.73% -27.52% -7.53% 9.18% -4.52% -28.26%
Return on Net Nonoperating Assets (RNNOA)
0.00% -15.43% 8.41% -0.75% 2.01% -17.68% -7.79% 12.65% -6.78% -52.11%
Return on Equity (ROE)
0.00% -22.56% 20.50% 19.88% 18.46% -38.77% -8.91% 27.89% 4.60% -67.87%
Cash Return on Invested Capital (CROIC)
0.00% -207.13% -69.79% 17.39% 10.02% -12.14% 12.25% -20.73% 41.69% -18.45%
Operating Return on Assets (OROA)
0.00% -1.66% 8.45% 10.35% 7.64% -10.22% -0.29% 6.13% 3.23% -7.01%
Return on Assets (ROA)
0.00% -4.48% 7.24% 6.41% 5.26% -8.73% -1.47% 3.87% 0.61% -7.53%
Return on Common Equity (ROCE)
0.00% -18.93% 17.22% 17.30% 16.71% -35.00% -7.92% 24.60% 4.06% -51.22%
Return on Equity Simple (ROE_SIMPLE)
0.00% -13.45% 19.54% 22.96% 20.18% -57.00% -10.66% 30.79% 5.52% -166.53%
Net Operating Profit after Tax (NOPAT)
120 -34 198 483 405 -513 -24 377 289 -344
NOPAT Margin
2.50% -0.82% 2.72% 4.72% 4.35% -7.02% -0.23% 1.91% 1.75% -2.90%
Net Nonoperating Expense Percent (NNEP)
0.00% -91.50% -199.06% 23.72% 10.71% 6.44% 6.41% 6.05% 15.90% 12.50%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 9.15% 8.12% -10.30%
Cost of Revenue to Revenue
88.60% 99.24% 94.06% 90.49% 90.43% 103.57% 97.65% 96.22% 96.67% 100.36%
SG&A Expenses to Revenue
7.76% 2.53% 2.42% 2.42% 2.95% 3.21% 1.88% 1.58% 1.65% 2.13%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
9.96% 1.93% 3.46% 3.53% 4.28% 6.45% 2.68% 1.47% 1.84% 3.78%
Earnings before Interest and Taxes (EBIT)
70 -50 377 605 488 -672 -19 460 248 -485
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
180 71 530 804 683 -404 246 735 588 -111
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
0.00 0.00 1.42 1.37 1.30 1.08 1.14 1.84 1.86 3.74
Price to Tangible Book Value (P/TBV)
0.00 0.00 3.19 3.34 3.09 6.40 16.42 0.00 0.00 0.00
Price to Revenue (P/Rev)
0.00 0.00 0.32 0.22 0.23 0.15 0.10 0.09 0.10 0.10
Price to Earnings (P/E)
0.00 0.00 8.10 6.58 6.96 0.00 0.00 6.74 79.62 0.00
Dividend Yield
3.68% 3.11% 2.09% 3.52% 3.92% 8.38% 0.00% 2.45% 3.75% 5.43%
Earnings Yield
0.00% 0.00% 12.35% 15.20% 14.38% 0.00% 0.00% 14.84% 1.26% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 1.32 1.25 1.19 1.03 1.06 1.27 1.44 1.39
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 0.42 0.29 0.33 0.33 0.20 0.19 0.19 0.26
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 5.75 3.71 4.45 0.00 8.76 5.05 5.29 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 8.10 4.94 6.21 0.00 0.00 8.07 12.51 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 15.40 6.18 7.50 0.00 0.00 9.83 10.76 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 9.53 5.33 5.27 0.00 5.80 8.73 3.07 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 7.33 12.30 0.00 8.07 0.00 2.94 0.00
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
0.00 0.70 0.75 0.99 1.13 2.09 2.19 2.86 2.71 4.81
Long-Term Debt to Equity
0.00 0.63 0.45 0.97 1.11 2.06 2.10 2.79 2.66 4.79
Financial Leverage
0.00 -0.18 0.04 0.24 0.35 0.64 1.04 1.38 1.50 1.84
Leverage Ratio
0.00 2.52 2.83 3.10 3.51 4.44 6.05 7.20 7.57 9.02
Compound Leverage Factor
0.00 19.87 2.25 2.49 2.89 5.07 43.97 5.04 0.51 13.12
Debt to Total Capital
0.00% 41.33% 42.73% 49.65% 52.97% 67.61% 68.63% 74.06% 73.04% 82.78%
Short-Term Debt to Total Capital
0.00% 4.19% 17.21% 0.89% 0.93% 0.96% 2.85% 1.81% 1.25% 0.28%
Long-Term Debt to Total Capital
0.00% 37.14% 25.52% 48.76% 52.04% 66.65% 65.77% 72.25% 71.79% 82.50%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 9.46% 9.14% 4.89% 4.33% 3.41% 3.71% 3.05% 3.21% 7.86%
Common Equity to Total Capital
0.00% 49.22% 48.13% 45.46% 42.70% 28.98% 27.67% 22.89% 23.75% 9.36%
Debt to EBITDA
0.00 11.81 2.77 2.22 3.03 -5.81 9.03 4.16 4.42 -24.98
Net Debt to EBITDA
0.00 -3.07 0.75 0.71 1.03 -2.96 4.14 2.52 2.41 -14.79
Long-Term Debt to EBITDA
0.00 10.62 1.65 2.18 2.98 -5.72 8.65 4.05 4.35 -24.89
Debt to NOPAT
0.00 -24.18 7.41 3.69 5.11 -4.58 -91.31 8.09 9.00 -8.04
Net Debt to NOPAT
0.00 6.28 2.00 1.19 1.74 -2.34 -41.89 4.91 4.91 -4.76
Long-Term Debt to NOPAT
0.00 -21.73 4.42 3.62 5.02 -4.52 -87.52 7.90 8.84 -8.01
Altman Z-Score
0.00 0.00 1.96 2.86 2.15 1.16 1.72 2.93 2.64 1.58
Noncontrolling Interest Sharing Ratio
0.00% 16.12% 16.02% 12.97% 9.46% 9.71% 11.14% 11.79% 11.83% 24.54%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
0.00 1.49 0.98 1.45 1.26 1.21 0.97 1.20 0.99 0.93
Quick Ratio
0.00 1.02 0.57 0.96 0.74 0.69 0.52 0.67 0.60 0.54
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -1,001 -1,142 407 247 -295 267 -513 1,058 -403
Operating Cash Flow to CapEx
96.51% 537.96% 185.98% 219.38% 144.96% -105.09% 176.60% 151.89% 259.50% -16.00%
Free Cash Flow to Firm to Interest Expense
0.00 -18.39 -12.17 3.02 1.88 -2.35 1.95 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
3.45 4.56 3.41 4.15 4.39 -2.25 2.72 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
-0.12 3.71 1.58 2.26 1.36 -4.39 1.18 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
0.00 1.41 1.63 1.75 1.46 1.11 1.64 2.64 2.14 1.71
Accounts Receivable Turnover
0.00 15.78 17.15 18.67 14.23 11.06 16.33 19.69 16.32 16.92
Inventory Turnover
0.00 10.62 11.38 12.46 10.35 9.03 10.46 13.71 12.94 12.97
Fixed Asset Turnover
0.00 3.80 4.48 4.72 4.02 3.05 4.56 7.79 6.02 4.21
Accounts Payable Turnover
0.00 8.39 9.29 9.32 6.44 5.51 7.32 11.07 8.94 6.56
Days Sales Outstanding (DSO)
0.00 23.13 21.29 19.55 25.65 33.00 22.36 18.53 22.37 21.58
Days Inventory Outstanding (DIO)
0.00 34.38 32.06 29.29 35.26 40.41 34.90 26.62 28.20 28.14
Days Payable Outstanding (DPO)
0.00 43.49 39.29 39.15 56.67 66.21 49.84 32.96 40.81 55.66
Cash Conversion Cycle (CCC)
0.00 14.02 14.06 9.69 4.25 7.20 7.42 12.20 9.75 -5.94
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
0.00 966 2,306 2,382 2,540 2,322 2,031 2,922 2,153 2,212
Invested Capital Turnover
0.00 8.69 4.44 4.37 3.78 3.00 4.89 7.99 6.49 5.43
Increase / (Decrease) in Invested Capital
0.00 966 1,340 76 158 -217 -291 891 -769 59
Enterprise Value (EV)
0.00 0.00 3,048 2,987 3,034 2,398 2,152 3,711 3,108 3,068
Market Capitalization
0.00 0.00 2,339 2,238 2,160 1,082 1,015 1,732 1,577 1,169
Book Value per Share
$0.00 $16.02 $20.26 $19.92 $22.45 $13.65 $12.06 $13.54 $13.22 $4.95
Tangible Book Value per Share
$0.00 $15.39 $9.00 $8.18 $9.43 $2.30 $0.83 ($1.67) ($2.03) ($7.66)
Total Capital
0.00 2,015 3,430 3,591 3,902 3,474 3,232 4,123 3,560 3,340
Total Debt
0.00 833 1,466 1,783 2,067 2,348 2,218 3,054 2,600 2,765
Total Long-Term Debt
0.00 749 875 1,751 2,031 2,315 2,126 2,979 2,555 2,756
Net Debt
0.00 -216 396 574 705 1,197 1,017 1,853 1,417 1,637
Capital Expenditures (CapEx)
187 46 172 255 397 269 210 280 391 418
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 -143 -402 -291 -312 -358 -871 -136 -796 -910
Debt-free Net Working Capital (DFNWC)
0.00 546 530 789 644 430 -15 705 25 -175
Net Working Capital (NWC)
0.00 462 -60 757 607 396 -107 631 -19 -184
Net Nonoperating Expense (NNE)
76 99 -125 109 68 61 71 87 242 177
Net Nonoperating Obligations (NNO)
0.00 -216 342 574 705 1,197 1,017 1,853 1,194 1,637
Total Depreciation and Amortization (D&A)
110 120 153 199 194 268 265 275 340 375
Debt-free, Cash-free Net Working Capital to Revenue
0.00% -3.41% -5.52% -2.84% -3.35% -4.90% -8.18% -0.69% -4.84% -7.68%
Debt-free Net Working Capital to Revenue
0.00% 13.01% 7.30% 7.71% 6.92% 5.88% -0.14% 3.56% 0.15% -1.47%
Net Working Capital to Revenue
0.00% 11.00% -0.82% 7.40% 6.53% 5.43% -1.00% 3.18% -0.12% -1.55%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $4.04 $0.00 $4.10 ($8.26) ($2.75) $3.63 $0.30 ($8.77)
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 71.57M 0.00 75.85M 73.60M 73.98M 70.79M 65.41M 63.88M
Adjusted Diluted Earnings per Share
$0.00 $0.00 $4.00 $0.00 $4.06 ($8.26) ($2.75) $3.59 $0.30 ($8.77)
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 72.30M 0.00 76.57M 73.60M 73.98M 71.52M 65.98M 63.88M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 83.92M 0.00 73.41M 73.78M 74.20M 66.94M 64.02M 62.51M
Normalized Net Operating Profit after Tax (NOPAT)
48 -64 126 483 405 -424 -41 352 184 -188
Normalized NOPAT Margin
1.01% -1.53% 1.74% 4.72% 4.35% -5.81% -0.38% 1.78% 1.12% -1.59%
Pre Tax Income Margin
0.45% -9.32% 4.12% 4.74% 4.33% -10.51% -1.29% 1.63% 0.10% -5.96%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
1.35 -0.91 4.01 4.48 3.72 -5.35 -0.14 0.00 0.00 0.00
NOPAT to Interest Expense
2.30 -0.63 2.11 3.58 3.09 -4.08 -0.18 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
-2.23 -1.76 2.18 2.59 0.70 -7.49 -1.68 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
-1.28 -1.48 0.28 1.69 0.06 -6.22 -1.72 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
132.72% -46.18% 26.97% 21.37% 25.82% -17.08% 0.00% 27.13% 129.12% -12.32%
Augmented Payout Ratio
229.29% -50.67% 34.72% 118.81% 78.79% -17.41% 0.00% 93.77% 311.99% -20.29%

Quarterly Metrics and Ratios for Delek US

This table displays calculated financial ratios and metrics derived from Delek US's official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Growth Metrics
- - - - - - - - - -
Revenue Growth
80.11% 29.81% -11.99% -29.87% -13.07% -7.83% -17.75% -18.45% -34.27% -41.90%
EBITDA Growth
5.06% -174.95% 105.19% -75.39% 131.04% -9.39% -44.88% -24.03% -110.43% -308.84%
EBIT Growth
-10.05% -648.79% 230.18% -90.02% 291.25% -18.44% -77.72% -72.78% -157.78% -154.78%
NOPAT Growth
37.62% -642.00% 203.43% -90.95% 302.27% -18.30% -80.46% -73.05% -149.55% -159.39%
Net Income Growth
-18.45% -2,050.98% 387.84% -100.41% 710.12% -45.94% -134.90% -1,640.00% -149.60% -151.16%
EPS Growth
-37.50% -870.59% 955.56% -102.57% 1,870.00% -50.91% -153.68% -346.15% -160.91% -160.24%
Operating Cash Flow Growth
72.91% -280.40% 1,374.25% -82.99% 232.26% 131.22% -57.81% -150.89% -104.99% -280.07%
Free Cash Flow Firm Growth
-160.94% -419.50% -295.04% 41.00% 134.26% 166.64% 151.04% 405.80% -2.65% -153.25%
Invested Capital Growth
24.19% 43.85% 34.98% 5.19% 0.80% -26.32% -10.14% -10.74% -9.26% 2.73%
Revenue Q/Q Growth
-10.99% -24.24% -12.39% 6.91% 10.33% -19.67% -20.29% 6.01% -11.09% -28.99%
EBITDA Q/Q Growth
-77.59% -155.53% 990.46% -40.42% 110.43% -126.29% 351.66% -17.88% -128.88% -930.82%
EBIT Q/Q Growth
-89.19% -353.45% 244.13% -66.91% 323.59% -176.73% 124.10% -59.58% -999.26% -238.30%
NOPAT Q/Q Growth
-88.96% -321.57% 261.71% -70.07% 391.03% -165.16% 123.75% -58.72% -1,002.96% -241.10%
Net Income Q/Q Growth
-95.44% -752.98% 165.82% -102.08% 9,173.33% -217.63% 84.26% -3.57% -158.62% -495.70%
EPS Q/Q Growth
-98.02% -1,750.00% 157.58% -113.68% 1,615.38% -226.40% 79.52% -13.73% -106.90% -440.00%
Operating Cash Flow Q/Q Growth
-76.71% -323.35% 235.87% -75.93% 354.89% -79.01% 83.59% -129.03% 55.37% -656.94%
Free Cash Flow Firm Q/Q Growth
-168.96% -121.70% 40.06% 83.11% 256.16% 331.24% -34.40% 1.21% -50.29% -335.89%
Invested Capital Q/Q Growth
-2.10% 16.79% -8.28% 0.31% -6.19% -14.63% 1.33% -0.36% -4.63% -3.35%
Profitability Metrics
- - - - - - - - - -
Gross Margin
2.65% -3.46% 6.04% 3.76% 6.01% -3.34% 4.03% 1.65% -0.66% -9.70%
EBITDA Margin
2.38% -1.74% 5.95% 3.31% 6.32% -2.07% 3.98% 3.09% -1.00% -14.55%
Operating Margin
1.00% -3.36% 3.64% 1.19% 4.58% -4.31% 1.01% 0.39% -4.01% -19.25%
EBIT Margin
1.01% -3.37% 3.82% 1.18% 4.54% -4.34% 1.03% 0.39% -3.99% -19.01%
Profit (Net Income) Margin
0.32% -2.72% 1.84% -0.04% 2.94% -4.31% -0.78% -0.76% -2.22% -18.61%
Tax Burden Percent
80.77% 59.01% 82.05% 28.30% 87.98% 72.51% 77.78% 77.22% 38.55% 86.53%
Interest Burden Percent
38.73% 136.59% 58.71% -10.69% 73.63% 136.97% -97.01% -250.37% 144.23% 113.15%
Effective Tax Rate
19.23% 0.00% 17.95% 0.00% 18.81% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
6.72% -18.80% 25.23% 5.71% 25.51% -19.58% 4.52% 1.68% -16.16% -73.16%
ROIC Less NNEP Spread (ROIC-NNEP)
4.41% -19.83% 21.72% 3.14% 22.72% -22.73% 1.24% -0.66% -14.85% -81.01%
Return on Net Nonoperating Assets (RNNOA)
4.41% -27.32% 26.56% 3.72% 24.06% -34.12% 1.68% -0.98% -19.12% -149.37%
Return on Equity (ROE)
11.12% -46.11% 51.79% 9.44% 49.58% -53.70% 6.20% 0.70% -35.28% -222.52%
Cash Return on Invested Capital (CROIC)
0.06% -20.73% -9.20% -1.26% 11.57% 41.69% 15.35% 15.02% 3.87% -18.45%
Operating Return on Assets (OROA)
2.51% -8.90% 9.57% 2.54% 9.61% -9.29% 2.24% 0.83% -7.42% -32.56%
Return on Assets (ROA)
0.79% -7.18% 4.61% -0.08% 6.23% -9.23% -1.69% -1.60% -4.13% -31.88%
Return on Common Equity (ROCE)
9.93% -40.67% 45.65% 8.48% 44.66% -47.34% 5.33% 0.59% -29.22% -167.93%
Return on Equity Simple (ROE_SIMPLE)
34.05% 0.00% 34.79% -2.36% 9.36% 0.00% -5.93% -9.34% -39.67% 0.00%
Net Operating Profit after Tax (NOPAT)
43 -95 117 35 172 -112 23 9.45 -85 -291
NOPAT Margin
0.80% -2.35% 2.99% 0.84% 3.72% -3.02% 0.71% 0.28% -2.80% -13.47%
Net Nonoperating Expense Percent (NNEP)
2.31% 1.03% 3.50% 2.57% 2.79% 3.14% 3.28% 2.34% -1.32% 7.85%
Return On Investment Capital (ROIC_SIMPLE)
- -2.30% - - - -3.15% - - - -8.71%
Cost of Revenue to Revenue
97.35% 103.46% 93.96% 96.24% 93.99% 103.34% 95.97% 98.35% 100.66% 109.70%
SG&A Expenses to Revenue
1.11% 2.03% 1.82% 1.81% 1.46% 1.53% 2.00% 1.84% 2.31% 2.54%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
1.65% -0.10% 2.40% 2.56% 1.42% 0.97% 3.02% 1.26% 3.34% 9.55%
Earnings before Interest and Taxes (EBIT)
54 -136 150 50 210 -161 33 14 -121 -411
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
127 -70 233 139 293 -77 129 106 -31 -314
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
1.54 1.84 1.45 1.59 1.70 1.86 2.25 1.95 1.72 3.74
Price to Tangible Book Value (P/TBV)
18.65 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
0.09 0.09 0.07 0.08 0.10 0.10 0.12 0.10 0.09 0.10
Price to Earnings (P/E)
4.93 6.74 4.60 0.00 26.78 79.62 0.00 0.00 0.00 0.00
Dividend Yield
1.59% 2.45% 3.84% 4.65% 4.02% 3.75% 3.89% 3.97% 5.28% 5.43%
Earnings Yield
20.26% 14.84% 21.76% 0.00% 3.73% 1.26% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
1.25 1.27 1.17 1.21 1.29 1.44 1.44 1.32 1.22 1.39
Enterprise Value to Revenue (EV/Rev)
0.17 0.19 0.16 0.18 0.19 0.19 0.21 0.20 0.20 0.26
Enterprise Value to EBITDA (EV/EBITDA)
3.48 5.05 3.48 6.87 5.09 5.29 6.55 6.36 16.04 0.00
Enterprise Value to EBIT (EV/EBIT)
5.04 8.07 5.24 21.75 10.64 12.51 20.78 24.10 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
6.40 9.83 6.52 32.56 10.47 10.76 29.25 33.91 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
3.57 8.73 3.94 9.85 5.15 3.07 4.43 4.93 14.91 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
2,345.50 0.00 0.00 0.00 11.19 2.94 8.90 8.28 30.05 0.00
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
2.13 2.86 2.47 2.64 2.28 2.71 2.41 2.50 2.95 4.81
Long-Term Debt to Equity
2.08 2.79 2.42 2.60 2.25 2.66 2.40 2.50 2.94 4.79
Financial Leverage
1.00 1.38 1.22 1.18 1.06 1.50 1.36 1.49 1.29 1.84
Leverage Ratio
6.71 7.20 7.50 6.96 6.67 7.57 6.93 7.19 7.09 9.02
Compound Leverage Factor
2.60 9.84 4.40 -0.74 4.91 10.37 -6.72 -18.01 10.22 10.20
Debt to Total Capital
68.06% 74.06% 71.17% 72.56% 69.51% 73.04% 70.69% 71.47% 74.69% 82.78%
Short-Term Debt to Total Capital
1.57% 1.81% 1.27% 1.28% 0.78% 1.25% 0.41% 0.28% 0.25% 0.28%
Long-Term Debt to Total Capital
66.49% 72.25% 69.90% 71.28% 68.74% 71.79% 70.28% 71.19% 74.43% 82.50%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
3.05% 3.05% 3.19% 3.14% 3.14% 3.21% 5.09% 5.14% 6.49% 7.86%
Common Equity to Total Capital
28.89% 22.89% 25.65% 24.30% 27.34% 23.75% 24.21% 23.39% 18.83% 9.36%
Debt to EBITDA
3.04 4.16 3.09 5.95 4.13 4.42 4.70 4.95 16.00 -24.98
Net Debt to EBITDA
1.36 2.52 1.73 3.44 2.14 2.41 2.59 2.85 7.71 -14.79
Long-Term Debt to EBITDA
2.97 4.05 3.03 5.84 4.08 4.35 4.68 4.93 15.95 -24.89
Debt to NOPAT
5.59 8.09 5.78 28.20 8.50 9.00 21.01 26.40 -19.84 -8.04
Net Debt to NOPAT
2.49 4.91 3.24 16.31 4.40 4.91 11.55 15.20 -9.56 -4.76
Long-Term Debt to NOPAT
5.46 7.90 5.68 27.70 8.40 8.84 20.89 26.30 -19.78 -8.01
Altman Z-Score
2.57 2.69 2.87 2.60 2.60 2.45 2.55 2.44 2.10 1.61
Noncontrolling Interest Sharing Ratio
10.69% 11.79% 11.85% 10.17% 9.92% 11.83% 14.09% 14.60% 17.20% 24.54%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
1.05 1.20 1.11 1.10 1.11 0.99 1.04 0.98 1.04 0.93
Quick Ratio
0.57 0.67 0.60 0.63 0.69 0.60 0.61 0.56 0.65 0.54
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-445 -986 -577 -98 152 657 295 298 148 -350
Operating Cash Flow to CapEx
137.63% -328.96% 186.99% 143.44% 1,027.55% 126.82% 352.43% -56.28% -21.01% -85.65%
Free Cash Flow to Firm to Interest Expense
-8.77 0.00 -7.55 -1.21 0.00 0.00 3.36 3.84 0.00 0.00
Operating Cash Flow to Interest Expense
2.57 0.00 5.16 1.18 0.00 0.00 1.90 -0.62 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.70 0.00 2.40 0.36 0.00 0.00 1.36 -1.73 0.00 0.00
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
2.49 2.64 2.51 2.15 2.12 2.14 2.17 2.10 1.86 1.71
Accounts Receivable Turnover
18.47 19.69 17.50 15.43 15.64 16.32 19.32 17.41 16.04 16.92
Inventory Turnover
13.14 13.71 12.70 11.27 11.75 12.94 13.28 13.07 13.04 12.97
Fixed Asset Turnover
7.56 7.79 7.65 6.48 6.25 6.02 5.71 5.46 4.89 4.21
Accounts Payable Turnover
9.35 11.07 8.60 7.82 7.95 8.94 8.86 7.76 7.34 6.56
Days Sales Outstanding (DSO)
19.76 18.53 20.86 23.65 23.33 22.37 18.90 20.97 22.76 21.58
Days Inventory Outstanding (DIO)
27.77 26.62 28.73 32.39 31.05 28.20 27.49 27.93 27.99 28.14
Days Payable Outstanding (DPO)
39.04 32.96 42.45 46.65 45.88 40.81 41.21 47.04 49.72 55.66
Cash Conversion Cycle (CCC)
8.48 12.20 7.14 9.39 8.50 9.75 5.18 1.86 1.02 -5.94
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
2,502 2,922 2,680 2,689 2,522 2,153 2,408 2,400 2,289 2,212
Invested Capital Turnover
8.36 7.99 8.45 6.84 6.86 6.49 6.38 6.07 5.76 5.43
Increase / (Decrease) in Invested Capital
487 891 695 133 20 -769 -272 -289 -234 59
Enterprise Value (EV)
3,130 3,711 3,127 3,245 3,252 3,108 3,477 3,162 2,795 3,068
Market Capitalization
1,788 1,732 1,447 1,498 1,767 1,577 1,924 1,568 1,210 1,169
Book Value per Share
$16.33 $13.54 $14.94 $14.32 $16.01 $13.22 $13.36 $12.56 $10.89 $4.95
Tangible Book Value per Share
$1.35 ($1.67) ($0.82) ($1.64) ($0.11) ($2.03) ($2.58) ($3.24) ($4.85) ($7.66)
Total Capital
4,017 4,123 3,899 3,874 3,795 3,560 3,532 3,445 3,735 3,340
Total Debt
2,734 3,054 2,775 2,811 2,638 2,600 2,497 2,462 2,789 2,765
Total Long-Term Debt
2,671 2,979 2,726 2,761 2,609 2,555 2,482 2,452 2,780 2,756
Net Debt
1,219 1,853 1,556 1,626 1,365 1,417 1,373 1,417 1,343 1,637
Capital Expenditures (CapEx)
95 88 211 66 42 72 47 86 103 191
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-891 -136 -499 -491 -542 -796 -637 -712 -930 -910
Debt-free Net Working Capital (DFNWC)
263 705 367 331 360 25 116 -54 107 -175
Net Working Capital (NWC)
200 631 317 282 331 -19 102 -64 98 -184
Net Nonoperating Expense (NNE)
26 15 45 37 36 48 48 36 -18 111
Net Nonoperating Obligations (NNO)
1,219 1,853 1,556 1,626 1,365 1,194 1,373 1,417 1,343 1,637
Total Depreciation and Amortization (D&A)
73 66 83 89 82 84 95 92 91 96
Debt-free, Cash-free Net Working Capital to Revenue
-4.72% -0.69% -2.53% -2.74% -3.14% -4.84% -3.93% -4.61% -6.71% -7.68%
Debt-free Net Working Capital to Revenue
1.39% 3.56% 1.86% 1.85% 2.09% 0.15% 0.72% -0.35% 0.77% -1.47%
Net Working Capital to Revenue
1.06% 3.18% 1.61% 1.57% 1.92% -0.12% 0.63% -0.41% 0.71% -1.55%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
$0.11 ($1.68) $0.96 ($0.13) $1.98 ($2.51) ($0.51) ($0.58) ($1.20) ($6.48)
Adjusted Weighted Average Basic Shares Outstanding
69.69M 70.79M 66.95M 65.77M 64.89M 65.41M 64.02M 64.21M 64.06M 63.88M
Adjusted Diluted Earnings per Share
$0.10 ($1.65) $0.95 ($0.13) $1.97 ($2.49) ($0.51) ($0.58) ($1.20) ($6.48)
Adjusted Weighted Average Diluted Shares Outstanding
69.69M 71.52M 67.37M 65.77M 65.46M 65.41M 64.02M 64.21M 64.06M 63.88M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
69.69M 66.94M 65.73M 64.82M 63.93M 64.02M 64.13M 64.54M 63.20M 62.51M
Normalized Net Operating Profit after Tax (NOPAT)
43 -95 117 35 172 -112 23 25 -79 -291
Normalized NOPAT Margin
0.80% -2.35% 2.99% 0.84% 3.72% -3.02% 0.71% 0.73% -2.59% -13.47%
Pre Tax Income Margin
0.39% -4.61% 2.24% -0.13% 3.34% -5.94% -1.00% -0.99% -5.76% -21.51%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
1.06 0.00 1.96 0.62 0.00 0.00 0.38 0.17 0.00 0.00
NOPAT to Interest Expense
0.84 0.00 1.53 0.44 0.00 0.00 0.26 0.12 0.00 0.00
EBIT Less CapEx to Interest Expense
-0.81 0.00 -0.80 -0.21 0.00 0.00 -0.16 -0.93 0.00 0.00
NOPAT Less CapEx to Interest Expense
-1.02 0.00 -1.23 -0.39 0.00 0.00 -0.28 -0.99 0.00 0.00
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
7.16% 27.13% 27.11% -574.77% 98.25% 129.12% -121.50% -57.37% -22.77% -12.32%
Augmented Payout Ratio
33.49% 93.77% 64.47% -1,340.54% 257.88% 311.99% -289.15% -117.13% -37.11% -20.29%

Frequently Asked Questions About Delek US's Financials

When does Delek US's financial year end?

According to the most recent income statement we have on file, Delek US's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Delek US's net income changed over the last 9 years?

Delek US's net income appears to be on a downward trend, with a most recent value of -$520.90 million in 2024, falling from $43.70 million in 2015. The previous period was $46.70 million in 2023.

What is Delek US's operating income?
Delek US's total operating income in 2024 was -$491.50 million, based on the following breakdown:
  • Total Gross Profit: -$43.10 million
  • Total Operating Expenses: $448.40 million
How has Delek US revenue changed over the last 9 years?

Over the last 9 years, Delek US's total revenue changed from $4.78 billion in 2015 to $11.85 billion in 2024, a change of 147.9%.

How much debt does Delek US have?

Delek US's total liabilities were at $6.09 billion at the end of 2024, a 2.0% decrease from 2023, and a 238.9% increase since 2016.

How much cash does Delek US have?

In the past 8 years, Delek US's cash and equivalents has ranged from $689.20 million in 2016 to $1.08 billion in 2018, and is currently $735.60 million as of their latest financial filing in 2024.

How has Delek US's book value per share changed over the last 9 years?

Over the last 9 years, Delek US's book value per share changed from 0.00 in 2015 to 4.95 in 2024, a change of 495.0%.

Remove Ads


This page (NYSE:DK) was last updated on 4/16/2025 by MarketBeat.com Staff
From Our Partners